The decreased NF-κB activity led to downregulated NF-κB–regulated cancer cell survival proteins, such as Bcl-2, Bcl-xL (B-cell lymphoma-extra large) and survivin, both in vitro and in vivo [28]. The gene discussed is NFKB1; the disease is cancer.